High delayed mortality after the first episode of Clostridium difficile infection

Autor: Dácil García, Alfonso Perales, Teresa Marrodán, Antonio Ramos-Martínez, Cristina Badia, Javier Cobo, Aguirre Elena, Ferrere Federico, Pedro Llinares, Alberto Cózar, Cristina Sardiña, Luis Torres, Alfonso Muriel, Elena Bereciartua, Sandra Cuellar, Isabel Fernández Morales, Alberto Delgado-Iribarren, Pedro A. De Santos-Castro, Livia Giner, Ana Royuela, Martínez-Ruiz S. Rocío, Miguel Salavert, Luis A. Sánchez Muñoz, Antonio Sánchez-Porto, M. Teresa Pérez-Rodríguez, Pilar Mairal, Juan Gálvez-Acebal, Evelyn Shaw, Purificación Martos, Helena Gil-Campesino, César Henríquez, Esther Calbo, Cristina Martínez García, J. María Bravo-Ferrer, Castelo Laura, Esperanza Merino, Gonzalez Eva, AngelBratos-Pérez Miguel, Jose R. Romero, Jordi Cuquet
Rok vydání: 2019
Předmět:
Zdroj: ANAEROBE
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
Digital.CSIC. Repositorio Institucional del CSIC
Anaerobe
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
ISSN: 1095-8274
1075-9964
Popis: Study group: José Romero; Alfonso Muriel; Livia Giner; Federico Ferrere; Rocío Martínez-Ruiz; Purificación Martos; Cristina Sardiña; Elena Aguirre; Cristina Badía; Alfonso Perales; Pedro A. De Santos-Castro; Angel Bratos-Pérez Miguel; Sandra Cuellar; Eva González; Pedro llinares; Laura Castelo; Isabel Morales; Alberto Delgado-Iribarren; Pilar Mairal
Clostridium difficile infection (CDI) is characterized by a high delayed and unrelated mortality. Predicting delayed mortality in CDI patients could allow the implementation of interventions that could reduce these events. A prospective multicentric study was carried out to investigate prognostic factors associated with mortality. It was based on a cohort (July 2015 to February 2016) of 295 patients presenting with CDI. Logistic regression was used and the model was calibrated using the Hosmer-Lemeshow test. The mortality rate at 75 days in our series was 18%. Age (>65 years), comorbidity (defined by heart failure, diabetes mellitus with any organ lesion, renal failure, active neoplasia or immunosuppression) and fecal incontinence at clinical presentation were associated with delayed (75-day) mortality. When present, each of the aforementioned variables added one point to the score. Mortalities with 0, 1, 2 and 3 points were 0%, 9.4%, 18.5% and 38.2%, respectively. The area under the ROC curve was 0.743, and the Hosmer-Lemeshow goodness-of-fit test p value was 0.875. Therefore, the prediction of high delayed mortality in CDI patients by our scoring system could promote measures for increasing survival in suitable cases.
Databáze: OpenAIRE